Company profile for 60 Degrees Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

60° Pharmaceuticals (60P) was founded in 2010 with a mission to realize new ways to improve and extend people’s lives by developing new best-in-class medicines for the treatment and prevention of tropical diseases. We apply the same passion, energy, and culture of innovation that make us commercially successful to making a difference in the world. We are committed to finding the tools and strategies that will help us overco...
60° Pharmaceuticals (60P) was founded in 2010 with a mission to realize new ways to improve and extend people’s lives by developing new best-in-class medicines for the treatment and prevention of tropical diseases. We apply the same passion, energy, and culture of innovation that make us commercially successful to making a difference in the world. We are committed to finding the tools and strategies that will help us overcome some of the planet’s greatest health challenges.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1025 Connecticut Avenue NW Suite 1000 Washington, D.C. 20036
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/21/3192770/0/en/60-Degrees-Pharmaceuticals-Announces-Clinical-Site-Now-Open-for-Patient-Enrollment-for-the-B-FREE-Chronic-Babesiosis-Study-at-Mount-Sinai-Icahn-School-of-Medicine.html

GLOBENEWSWIRE
21 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187746/0/en/60-Degrees-Pharmaceuticals-Announces-Third-Quarter-2025-Results.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/10/15/3166954/0/en/60-Degrees-Pharmaceuticals-Announces-No-Detection-of-Babesia-Infection-in-First-Patient-Following-Treatment-with-Tafenoquine-in-Relapsing-Babesiosis-Study.html

GLOBENEWSWIRE
15 Oct 2025

https://www.globenewswire.com/news-release/2025/10/09/3164021/0/en/60-Degrees-Pharmaceuticals-Unveils-Name-of-Chronic-Babesiosis-Clinical-Trial-B-FREE-Chronic-Babesiosis-Study.html

GLOBENEWSWIRE
09 Oct 2025

https://www.globenewswire.com/news-release/2025/08/21/3137147/0/en/60-Degrees-Pharmaceuticals-to-Present-at-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

GLOBENEWSWIRE
21 Aug 2025

https://www.globenewswire.com/news-release/2025/08/19/3135722/0/en/60-Degrees-Pharmaceuticals-Selects-Icahn-School-of-Medicine-at-Mount-Sinai-as-Central-Clinical-Trial-Site-for-Phase-II-Study-to-Evaluate-Tafenoquine-for-Chronic-Babesiosis.html

GLOBENEWSWIRE
19 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty